4.8 Review

Insights into the unique functionality of inorganic micro/nanoparticles for versatile ultrasound theranostics

Journal

BIOMATERIALS
Volume 142, Issue -, Pages 13-30

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2017.07.016

Keywords

Inorganic biomaterials; Microbubbles; Ultrasound biomedicine; Theranostics; Nanomedicine

Funding

  1. National Key R&D Program of China [2016YFA0203700]
  2. Zhengjiang Medical Key Talents, National Natural Science Foundation of China [51672303]
  3. Young Elite Scientist Sponsorship Program by CAST [2015QNRC001]
  4. Youth Innovation Promotion Association of the Chinese Academy of Sciences [2013169]
  5. Development Fund for Shanghai Talents

Ask authors/readers for more resources

The clinical ultrasound (US)-based theranostic biomedicine suffers from the critical issue that traditional microbubbles (MBs) have lots of drawbacks such as low stability, large particle size, difficult structural control, etc. The unique composition, structure and functionality of inorganic micro/nanoplatforms have shown their great prospect for solving these critical issues and drawbacks of traditional organic MBs. This review summarizes and discusses the state-of-art development on exploring inorganic micro/nanoparticles for versatile US-based biomedical applications, ranging from US imaging, photoacoustic imaging, sonodynamic therapy, high intensity-focused US ablation and US-triggered chemotherapy. These inorganic micro/nanoplatforms include silica-based particles, Au, carbon nanotubes, TiO2, manganese oxide, iron oxide, Prussian blue, inorganic gas-generating nanoparticles and their versatile composite micro/nanosystems. Especially, their unique structure/composition-functionality relationships and biocompatibility/biosafety in US-based theranostics have been discussed and revealed in detail. Their facing challenges and future developments are finally discussed to promote their further clinical translations. It is highly expected that these inorganic micro/nanoplatforms will enter the clinical stage to benefit the personalized theranostics biomedicine based on their unique functionalities and high performance as necessarily required in US-based theranostics. (C) 2017 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available